Pharmacy Models for Expanding Access to COVID-19 Monoclonal Antibody Treatment

Registration is a 2-step process! 

Select 'ENROLL NOW' to register and gain access to the link that will allow you to complete part 2 of the 2-step registration process.

Thursday, June 10, 2021 (1:00PM - 2:00PM EDT)

*Pre-registration is required to participate.

Activity Preview

APhA is collaborating with the American Society of Consultant Pharmacists (ASCP) to discuss pharmacy models for increasing awareness of and access to monoclonal antibody therapies for the treatment of COVID-19 infection in vulnerable populations. This webinar will cover what you need to know about the available therapy options and how you can help make eligible patients aware of the benefits of accessing treatment. Our expert panelists will outline key components of pharmacy practices that are successfully providing monoclonal antibody therapies to patients in their communities. 

Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  • Describe the clinical considerations for monoclonal antibody therapies authorized for treatment of COVID-19 infection under emergency use.
  • Identify patients eligible to receive monoclonal antibody therapy and access to treatment.  
  • Describe pharmacy practice models that can be implemented to increase awareness of and access to monoclonal antibody therapies.

Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2

Accreditation Information

ACPE Logo

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following webinar is approved for 1.0 contact hours of CPE credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-239-L01-P.

To obtain credit for completing Pharmacy Models for Expanding Access to COVID-19 Monoclonal Antibody Treatment participants will need to complete the 2-step registration process, attend the live webinar, complete the evaluation questions, and then CLAIM credit. An attendance code and detailed instructions on how to claim credit will be provided during the webinar. Participants need to have a valid pharmacist.com username and password, as well as a CPE Monitor account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript. 

Initial release date: June 10, 2021
Expiration date to claim credit for LIVE webinar: August 09, 2021 (11:59PM EDT) 

Development

Pharmacy Models for Expanding Access to COVID-19 Monoclonal Antibody Treatment is a live continuing education activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association.

Disclosures

Disclosures will be presented day of webinar. APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures

Fee

There is no fee associated with this activity. This learning product is conjunction with the APhA Open Forum Webinar series.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Pharmacy Models for Expanding Access to COVID-19 Monoclonal Antibody Treatment

Date 6/10/2021 1:00:00 PM
Address Virtual - Go To Webinar
City Washington State District of Columbia Zip Code 20037